Dr. Brad Swarbrick

Brad Swarbrick is Managing Director and Cofounder of KAX Group in Australia and is globally recognized for his expertise in Process Analytical Technology (PAT), chemometrics, and multivariate data analysis. With over 25 years of experience, he has played a pivotal role in the application of near and mid-infrared spectroscopy, vibrational spectroscopy, and model-based control strategies—especially in the pharmaceutical industry.

Previously a member of Pfizer’s global PAT team, Swarbrick has also served as Chief Operating Officer for a leading multivariate data analysis software provider and proprietor of Quality by Design Consultancy. He holds a PhD in biospectroscopy and advanced chemometrics from the University of Sydney. Brad is the pharmaceutical section editor of the Journal of Near Infrared Spectroscopy and is active in working groups on process communications, PAT, and Quality by Design (QbD) in global industry forums.

Brad Swarbrick’s leadership at KAX Group has focused on developing intuitive, easy-to-use data analysis and visualization software, helping organizations across life sciences, food and beverage,petrochemical, and agritech sectors solve complex process and product challenges using advanced analytical solutions.